BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2059-0105
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children ; volume:7 ; number:1 ; day:3 ; month:12 ; year:2022 ; pages:1-10 ; date:12.2022
npj vaccines ; 7, Heft 1 (3.12.2022), 1-10, 12.2022

Urheber
Bartsch, Yannic C.
Chen, Jessica W.
Kang, Jaewon
Burns, Madeleine D.
Denis, Kerri J. St
Sheehan, Maegan L.
Davis, Jameson P.
Edlow, Andrea G.
Balazs, Alejandro B.
Yonker, Lael M.
Alter, Galit
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41541-022-00575-w
URN
urn:nbn:de:101:1-2023021421232568803143
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:51 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bartsch, Yannic C.
  • Chen, Jessica W.
  • Kang, Jaewon
  • Burns, Madeleine D.
  • Denis, Kerri J. St
  • Sheehan, Maegan L.
  • Davis, Jameson P.
  • Edlow, Andrea G.
  • Balazs, Alejandro B.
  • Yonker, Lael M.
  • Alter, Galit
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Heme induces trained immunity

Hochschulschrift

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Verbundene Objekte